Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.
Plötz
Sabine-Gisela
SG
Division of Environmental Dermatology and Allergy GSF/TUM, the Center for Allergy and Environment, Technical University, Munich, Germany.
Simon
Hans-Uwe
HU
Darsow
Ulf
U
Simon
Dagmar
D
Vassina
Ekatherina
E
Yousefi
Shida
S
Hein
Rüdiger
R
Smith
Tim
T
Behrendt
Heidrun
H
Ring
Johannes
J
D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018791:CD4 Lymphocyte Count; D016207:Cytokines / Q000097:blood; D003872:Dermatitis / Q000188:drug therapy* / Q000276:immunology; D004804:Eosinophils; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000276:immunology; D007262:Infusions, Intravenous; D015848:Interleukin-5 / Q000276:immunology*; D007958:Leukocyte Count; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D015848:Interleukin-5; C434107:mepolizumab